Norwood, Mass.— Colliers has facilitated a lease renewal for Corbus Pharmaceuticals Holdings, Inc. at 500 River Ridge Drive in Norwood, extending the company’s presence in a key suburban office and life sciences corridor.
The renewal covers 36,471 square feet at the Class A office property within River Ridge Office Park. Colliers Vice Chair Curtis Cole, Vice President Sean Hannigan, and Senior Vice President Tim Allen represented the tenant in the transaction. JLL, led by Nat Kessler, represented the landlord, River Ridge Limited Partnership.
Located along Route 1 with access to Route 128 and Interstate 95, the property provides connectivity to Greater Boston’s business and life sciences hubs. The site has continued to attract tenants seeking suburban office space with proximity to major transportation routes.
Corbus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatments for cancer and obesity. The lease renewal supports the company’s ongoing operations and research activities in the region.
“Representing Corbus Pharmaceuticals in this renewal was about making sure the terms and the location worked for their business, today and into the future,” said Hannigan.
Sean Moran, chief financial officer of Corbus Pharmaceuticals, said the company’s decision to renew reflects confidence in the location and the broader regional ecosystem. “Greater Boston’s life sciences ecosystem, combined with our established presence here, positions us well as we move forward with our pipeline and business objectives,” he said.
According to Colliers’ 2026 Life Sciences Market Outlook, Greater Boston has seen a 20% increase in research-focused life sciences space over the past five years, supported by a strong workforce and more than $8 billion in venture capital investment.
The transaction underscores continued demand for well-located office and research space in the Greater Boston market.
